ISRN Endocrinology · 2014 · 103 citations · 13 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyDiabetic Foot CareDiabetologyDiabetes MellitusDiabetic Foot DiseaseDiabetic Foot UlcerationDiabetic Neuropathic FootFoot Ulcer PreventionUlcer ManagementDiabetic Foot DisordersDiabetic Foot Ulcer PharmacotherapyFoot Ulcer HealingPlacebo ComparatorsUlcer Size Measurement
Objective. The effect of a proprietary formulation of trans-resveratrol (t-RSV) on manifestations of diabetic foot syndrome (DFS) was studied in type 2 diabetic patients with newly diagnosed diabetic foot ulcers. Method. Placebo-controlled, examiner-blinded, parallel-group randomized controlled pilot clinical trial (ACTRN Clinical Trial Registry number 12610000629033) involving 24 patients with DFS (15 males and 9 females, average age of 56.4 ± 9.1 years) divided into the placebo and RSV-treatment groups was performed. 50 mg of t-RSV or placebo capsules was given to each patient twice a day over a 60-day time period. Results. Reduction in the parameters reflecting diabetic ulcer size was more profound in the RSV group as compared to placebo. RSV-treated patients also had a marginally improved performance in the foot pressure test. A statistically significant decline in the plasma fibrinogen level, but not CRP, was also found in the RSV-treated patients. Some improvement in the plasma lipid profile and fasting glucose levels were not related to RSV-treatment, since they have been seen on both the RSV and placebo groups, revealing the effectiveness of medical supervision and education in the newly diagnosed patients with DFS. Conclusion. t-RSV supplementation promotes reduction of the foot ulcer size and reduces plasma fibrinogen level in type 2 diabetic patients.
13
High-Dose Resveratrol Supplementation in Obese Men
Morten Møller Poulsen, P. Vestergaard, Berthil F. Clasen et al. · Diabetes · 2012 · 443 citations · Full text
João Tomé‐Carneiro, Manuel Gonzálvez, Mar Larrosa et al. · The American Journal of Cardiology · 2012 · 256 citations